SCPH – scpharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Maxim Group from $20.00 to $12.00. They now have a "buy" rating on the stock.
scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
Form S-8 scPharmaceuticals Inc.
Form 10-K scPharmaceuticals Inc. For: Dec 31
Form 8-K scPharmaceuticals Inc. For: Mar 19
Form 4 scPharmaceuticals Inc. For: Feb 11 Filed by: Tucker John H
Form 4 scPharmaceuticals Inc. For: Feb 11 Filed by: Nokes Rachael
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.